Cite
HARVARD Citation
Naganuma, M. et al. (2019). Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System. SAGE open medicine. p. . [Online].